2-substituted-3-indolamines and use thereof as anti-diabetics
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 15, 1986
Issued Date -
N/A
app pub date -
Jun 16, 1983
filing date -
Jun 10, 1982
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This disclosure relates to substituted indolamines, which exhibit anti-diabetic activity, having the formula: ##STR1## where m is an integer from 1 to 4, x represents hydrogen or --OH R represents Ar or ##STR2## and Ar represents ##STR3## R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl or lower alkoxy, R.sub.2 and R.sub.3 each, independently, represent lower alkyl, or R.sub.2 and R.sub.3 together with N represent ##STR4## wherein n is 1, 2 or 3, R.sub.4 represents hydrogen or lower alkyl, and R.sub.5 represents hydrogen or lower alkyl, unsubstituted phenyl or phenyl substituted with fluoro, chloro, lower alkyl or lower alkoxy, or or pharmaceutically acceptable acid addition salts thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully